Proficio Capital Partners LLC Pfizer Inc Transaction History

Proficio Capital Partners LLC

$969 Million
Q3 2024

A detailed history of Proficio Capital Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Proficio Capital Partners LLC holds 9,837 shares of PFE stock, worth $261,860. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,837

Previous 9,539 3.12%

Holding current value

$261,860

Previous $266,000 6.77%

% of portfolio

0.03%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$27.7 - $31.39 $8,254 - $9,354	298 Added 3.12%	9,837 $284,000
Q2 2024 Jul 25, 2024	SELL	$25.26 - $29.6 $8,386 - $9,827	-332 Reduced 3.36%	9,539 $266,000
Q1 2024 May 02, 2024	SELL	$25.89 - $29.73 $34,847 - $40,016	-1,346 Reduced 12.0%	9,871 $273,000
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $564,852 - $733,680	-21,617 Reduced 65.84%	11,217 $322,000
Q3 2023 Oct 18, 2023	BUY	$32.09 - $37.51 $18,034 - $21,080	562 Added 1.74%	32,834 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $87,518 - $101,257	-2,423 Reduced 6.98%	32,272 $1.18 Million
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $32.5 Million - $42.3 Million	-824,676 Reduced 95.96%	34,695 $1.42 Million
Q1 2023 Apr 19, 2023	BUY	$39.39 - $51.28 $32.4 Million - $42.2 Million	822,988 Added 2262.01%	859,371 $35.1 Million
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $81,537 - $106,438	1,953 Added 5.67%	36,383 $1.86 Million
Q3 2022 Oct 11, 2022	SELL	$43.76 - $53.42 $59,513 - $72,651	-1,360 Reduced 3.8%	34,430 $1.51 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $32,105 - $38,067	690 Added 1.97%	35,790 $1.88 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $28,731 - $35,601	628 Added 1.82%	35,100 $1.82 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $20,329 - $30,135	-492 Reduced 1.41%	34,472 $2.04 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $50,946 - $65,445	-1,298 Reduced 3.58%	34,964 $1.5 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $462,736 - $524,202	-12,886 Reduced 36.43%	22,482 $880,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $494,839 - $560,570	13,780 Added 61.29%	36,262 $1.42 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $272,709 - $307,561	8,143 Added 29.91%	35,368 $1.28 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $44,983 - $57,200	-1,344 Reduced 4.7%	27,225 $1 Million
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $621,506 - $729,168	19,575 Added 217.65%	28,569 $1.02 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $91,655 - $111,191	-3,043 Reduced 25.28%	8,994 $295,000
Q1 2020 May 06, 2020	BUY	$27.03 - $38.62 $39,869 - $56,964	1,475 Added 13.97%	12,037 $328,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $67,123 - $76,177	2,039 Added 23.92%	10,562 $414,000
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $153,157 - $198,600	-4,714 Reduced 35.61%	8,523 $306,000
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $137,454 - $154,329	3,717 Added 39.04%	13,237 $573,000
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $131,325 - $144,282	3,502 Added 58.19%	9,520 $404,000
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $11,502 - $13,114	299 Added 5.23%	6,018 $263,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $9,203 - $11,163	-267 Reduced 4.46%	5,719 $252,000
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $1,945 - $2,074	59 Added 1.0%	5,986 $217,000
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $3,637 - $4,220	114 Added 1.96%	5,927 $210,000
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $3,791 - $4,023	114 Added 2.0%	5,813 $211,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $176,669 - $194,620	5,699	5,699 $203,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.

Account

Proficio Capital Partners LLC Pfizer Inc Transaction History